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Summary 
A  human receptor that is selective for the  CXC  chemokines IP10 and Mig was  cloned and 
characterized. The receptor cDNA has an open reading frame of 1104-bp encoding a protein 
of 368 amino acids with a molecular mass of 40,659 dalton. The sequence includes seven puta- 
tive transmembrane segments characteristic of G-protein coupled receptors. It shares 40.9 and 
40.3% identical amino acids with the  two  IL-8 receptors,  and 34.2-36.9%  identity with the 
five known CC chemokine receptors. The IPl0/Mig receptor is highly expressed in IL-2-acti- 
vated T  lymphocytes, but is not detectable in resting T  lymphocytes, B lymphocytes, mono- 
cytes and granulocytes. It mediates Ca  2+ mobilization and chernotaxis in response to IP10 and 
Mig, but does not recognize the CXC-chemokines IL-8, GROom,  NAP-2,  GCP-2, ENA78, 
PF4,  the CC-chemokines MCP-1,  MCP-2, MCP-3, MCP-4, MIP-lot, MIP-I[~, RANTES, 
I309,  eotaxin,  nor lymphotactin.  The  exclusive expression in  activated T-lymphocytes is  of 
high interest since the receptors for chemokines which have been shown so far to attract lym- 
phocytes, e.g., MCP-1, MCP-2, MCP-3, MIP-lot, MIP-I[3, and R_ANTES, are also found in 
monocytes and granulocytes. The present observations suggest that the  IP10/Mig receptor is 
involved in the selective recruitment of effector T  cells. 
C  hemokines constitute a family of small cytokines that 
are produced in inflammation and regulate leukocyte 
recruitment  (1-3).  Two  subfamilies,  CXC  and  CC  che- 
mokines, are distinguished by the  arrangement of the first 
two of four conserved cysteines which are separated by one 
amino acid or are adjacent. Most CXC-chemokines attract 
neutrophil leukocytes whereas CC-chemokines are less se- 
lective and attract monocytes, eosinophil and basophil leu- 
kocytes,  T-lymphocytes  and  natural  killer  cells.  All 
chemokines  act  through  G  protein-coupled,  seven  trans- 
membrane domain receptors  (4,  5).  Two of these,  the in- 
terleukin-8  (IL-8) 1 receptors, IL-8R1  (6)  and IL-8R2 (7), 
are  largely restricted  to  neutrophil  leukocytes  and  recog- 
nize  the  NH2-temlinal Glu-Leu-Arg (ELR)  motif,  an es- 
~  Abbreviations used in this paper: CC-CKR, CC-chemokine receptor; Mig, 
rnonokine induced by interferon-gamma;  IP10, interferon-gamma  induc- 
ible 10-kD protein; NAP-2, neutrophil-activating  protein-2; ENA78, epi- 
thelial-derived neutrophil-activating peptide-78; GCP-2, granulocyte 
chemotactic protein-2; PF4, platelet factor-4; RANTES, regulated on ac- 
tivation, normal T cell expressed  and secreted; MCP, monocyte chemo- 
tactic protein; MIP, macrophage inflammatory  protein; [Ca2+]i, intracel- 
lular calcium ion concentration. 
sential binding epitope in those CXC-chemokines that in- 
duce  neutrophil  chemotaxis  (8-10).  Five  distinct  CC- 
chemokine receptors  have been  described  and  designated 
CC-CKR1, 2, 3, 4, and 5  (11-17).  They occur on several 
types ofleukocytes, including monocytes, granulocytes and 
lymphocytes,  and  recognize  CC  but  not  CXC  chemo- 
kines. 
By contrast to monocytes and granulocytes, T-lympho- 
cyte responses to chemokines are not well understood. No- 
tably, none of the known receptors is expressed exclusively 
in  lymphocytes and  the  chemokines that  recognize  these 
receptors  cannot,  therefore,  account  for  the  selective  re- 
cruitment  of T-lymphocytes  that  is  observed in  T  cell- 
mediated  inflammatory  conditions.  Here  we  describe  a 
cDNA from human CD4 + T  cells,  which was not present 
in  monocyte  or  granulocyte  derived  cDNA  libraries  and 
which encodes a novel chemokine receptor that is selective 
for IP10 and Mig. 
Materials and Methods 
Human  Chemokines.  The  CXC-chemokines  Mig,  IL-8, 
GROe~,  NAP-2,  GCP-2,  ENA78,  PF4,  the  CC-chemokines 
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I309,  eotaxin,  and  the  chemokine-related  lymphotactin  were 
chenfically synthesized according to established protocols (18). The 
CXC-chemokine  IP10  was purchased from PeproTech  (Rocky 
Hill, NJ). 
Cloning of Receptor cDNA.  Novel DNA fragments coding for 
putative T-lymphocyte-restricted chemokine receptors were gener- 
ated using the following polymerase chain reaction (PCR) proto- 
col. Two degenerate oligonucleotide primers to conserved motifs 
of chemokine receptors (5'-GGGCTGCAGCIIT(T/G) (T/G)C 
(C/A)GAC(A/C)TICTI(C/T)T  and  5'-GGGTCTAGAIGG- 
GTTIAI(G/A)CA(G/A)C(T/A)(G/A)(T/C)G, I =  inosine) were 
used  to  PCR  amplify DNA  fragments  from  human  genomic 
DNA. The designed primer sequences were based on the highly 
conserved nucleotide sequences within transmembrane domain-2 
(TM2)  and TM7 of the chenmkine receptors IL-8R1,  IL-8R2, 
CC-CKR1,  CC-CKR2  and  the  orphan  receptors  EBI  I  (19), 
LESTR (20) and BLR1/MDR15  (21, 22).  I00 ILl reaction mix- 
ture  containing  2  btg  human  genomic  DNA,  l X-DynaZyme 
buffer  (Finnzymes OY,  Espoo,  Finland),  1.5  mM  MgC12, 500 
~M of each deoxynucleotide, 1 I-tM of both primers and 2.5-U 
of  DynaZyme  DNA  polymerase  was  subjected  to  30-cycles 
(94~  for ] rain, 55~  for 1 min, and 72~  for 2 min) on a DNA 
thermal  cycler  (Techne  PHC-2,  Brouwer,  Switzerland).  PCR 
products of the predicted size  (~700-bp)  were  cloned into the 
Gene Scribe-Z vectors pTZ18/19-U/R  (USB, Cleveland, OH), 
partially sequenced  (23),  and  evaluated  for  their  similarity to 
known chemokine receptors and expression of their correspond- 
ing mRNA in leukocytes. The DNA fragment 2MLC22 revealed 
64%  nucleotide sequence identity with  IL-8R2  and specifically 
hybridized to RNA from T  cells but not monocytes or neutro- 
phils. Using 2MLC22 as screening probe, 23 positive clones were 
isolated  from  a  human  tetanus  toxoid-specific  CD4 +  T  cell 
(KT30)  cDNA library, prepared in lambda-ZAP Express (Strata- 
gene,  Zurich,  Switzerland).  The  clone  with  the  largest insert 
(1,670  bp) was sequenced to completion. 
Northern Blot Analysis.  l()-I.tg samples of total RNA were ex- 
amined from freshly isolated human  blood monocytes, neutro- 
phils, lymphocytes (PBL),  nylon wool-purified T  cells, and from 
cultured cells, including cloned human CD4 + and CD8 + T  cells 
(KT30 and ERCD8,  respectively), cloned NK-cells (ERNK57) 
and PBL cultured for 10 d (i-2.5 ￿  106 cells/ml in R.PMI-1640 
medium  containing 2  mM  glutamine,  1￿  non-essential amino 
acids, l mM sodium pyruvate, 100 I~g/ml kanamycin, 5 ￿  10 -5 M 
2-mercaptoethanol, and 5% human serum) in the presence of 400 
U/ml hrlL-2. RNA samples were analyzed with 32p-labeled  5'- 
fraganent  of the  IPl0/MigR DNA  (10  9 cpm/~g DNA) at 5  ￿ 
I0  ~' cpm/ml hybridization solution as described (20). 
Receptor Transfectants.  To  generate  stable  transfectants,  4  X 
10  ~' of either mouse pre-B cells (300-19)  (24), human promyelo- 
cytic cells  (GM-1)  (25)  or human  acute  T  cell leukemia cells 
(Jurkat)  (26)  were transfected by electroporation with 20 I,  zg of 
receptor cDNA in pcDNA3,  linearized with BgllI as described 
(27).  IP10/MigR transfected cells were cloned by limited dilu- 
tion under selection of G-418 (Life Technologies, Inc., Gaithers- 
burg, MD)  at  1.0  mg/ml for 300-19  and 0.8  mg/ml for Jurkat 
and GM-1 cells. G 418-resistant clones were screened for recep- 
tor expression by 1LNA Dot blot analysis. 
Ca 2+ Changes.  Changes in the cytosolic free Ca  2+ concentra- 
tion ([Cae+]i) were measured in cells loaded with fura-2 by incu- 
bation for 30 rain at 37~  with 0.1  nmol fura-2 acetoxymethyl- 
ester per 10  ~' cells in a buffer containing 136 mM NaC1,  4.8 mM 
KC1, 1 mM CaCI2, 5 mM glucose, and 20 mM Hepes, pH 7.4. Af- 
ter centrifugation, loaded cells were resuspended in the same buf- 
fer (1 (I  ~ cells/ml), stimulated with the indicated chemokine at 37~ 
and the [Ca2+Ji-related  fluorescence changes were recorded (28). 
Chemotaxis.  Cell migration was assessed in 48-well chambers 
(Neuro Probe, Cabin John, MD) using polyvinylpyrrolidone-free 
polycarbonate membranes  (Nucleopore)  with  5-Ltm  pores  for 
IP10/MigR transfected cells (26) or 3-1*m pores for human  PBL 
(29). RPMI 1640 supplemented with 20 mM Hepes, pH 7.4, and 
1% pasteurized plasma protein solution (Swiss Red Cross Labora- 
tory,  Bern,  Switzerland)  was  used  to  dissolve the  chemokines 
(lower wells), and to dilute the cells  (100,000  receptor transfec- 
tants or PBL in the upper well). After 60 min at 37~  the mem- 
brane was  removed, washed on the upper side with  PBS,  fixed 
and stained. All assays were done in triplicate, and the migrated 
cells were counted in five randomly selected fields at  t,000-fold 
magnification. Spontaneous migration was determined in the ab- 
sence of chemoattractant. 
Results  and Discussion 
Receptor cDNA.  During  a  search  for  T-lymphocyte- 
specific  chemokine  receptors  we  have  isolated  a  cDNA 
from a human  CD4 + T  cell library, which was not present 
in  commonly  used  monocyte  or  granulocyte  derived 
cDNA libraries. This cDNA, which is shown below to en- 
code the IP10/Mig receptor, has an open reading flame of 
1,104  bp  corresponding  to  a  protein  of 368  amino  acids 
with a molecular mass of 40,659  dalton. The sequence in- 
dudes seven putative transmembrane  segments,  which  are 
characteristic for G protein-coupled receptors, three poten- 
tial  N-glycosylation sites  (Asn  22,  Asn  32,  and  Asnl')')), and 
one  threonine  and nine  serine residues in the intracellular 
COOH-terminal  region as potential phosphorylation sites 
for receptor kinases (30-32)  (Fig. 1). A  truncated version of 
this clone, with an incomplete coding sequence, was previ- 
ously isolated from  a  human  genomic  DNA  library (33). 
Alignment with the other chemokine receptors reveals sev- 
eral  conserved  motifs  particularly  in  the  transmembrane 
domains  and  the  second  intracellular loop.  Considerable 
identity  with  IL-8tL1  and  IL-8R2,  but  not  with  CC- 
chemokine receptors is observed in the third and the sixth 
transmembrane  domains  (Fig.  1).  The  novel  sequence 
shares 40.9  and 40.3%  identical amino acids with  the  two 
IL-8  receptors,  and  34.2  to  36.9%  identity with  the  five 
known CC chemokine receptors (Table 1). A lower degree 
of similarity was found with seven-transmembrane-domain 
receptors  that  are  expressed  in  T  cells  but  do  not  bind 
chemokines, e.g., 27.2% identity with the thrombin recep- 
tor (34). 
Receptor Function in Transfected Cells.  To  determine whether 
the  receptor was  functional,  clones  of murine  pre-B  cells 
(300-19),  human  promyelocytic cells (GM-1),  and human 
T  cell leukemia  (Jurkat)  were  stably transfected  with  the 
new  receptor  cDNA.  Activation of chemokine  receptors 
leads to a transient rise of the cytosolic free Ca  2+  concen- 
tration ([Ca2+]i), and this assay was used to monitor signal- 
ing in  the  transfected  cells.  A  rapid  [Ca2+]i  rise  was  ob- 
served  in  response  to  IPl0  and  Mig.  IP10  was  described 
more than ten years ago, and shown to be expressed in cu- 
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Figure  1.  Amino acid sequence alignment of the novel receptor (IPl0/MigR) with other human chemokine receptors.  Multiple protein alignment 
was performed according to Higgins and Sharp (51). The black areas show regions of identity between IPI0/MigR and at least two other chemokine re- 
ceptors.  Arrowheads indicate potential N-linked glycosylation  sites and horizontal lines the putative transmembrane domains (TM1-TM7). Amino acids 
are abbreviated: A, Ala; C, Cys: D, Asp; E, Glu; F, Phe; G, Gly;/4, His; I, lie; K, Lys; L, Leu; M, Met; N, Ash; P, Pro; Q, Gin; R, Arg; S, Ser; T, Thr; 
V, Val; W, Tri0; and Y, Tyr. These sequence data are available from EMBL/Genbank/DDBJ under accession number X95876. 
taneous  delayed-type  hypersensitivity  reactions  (35,  36) 
while  Mig  was  identified  more  recently  (37,  38).  Both 
chemokines  have  the  CXC  arrangement  of the  first  two 
cysteines like IL-8, but are not chemotactic for neutrophil 
leukocytes.  It was recently shown that IP10 attracts T-lym- 
phocytes (39,  40) and that Mig is chemotactic for tumor- 
associated lymphocytes (41). 
Fig.  2  summarizes  the  effects  of IP10  and Mig on cells. 
transfected  with  the cDNA  and expressing the  functional 
IP10/MigR.  As shown by the [Ca2+]i changes the action of 
IP10  and  Mig  was  concentration  dependent  and  already 
detectable at  1 nM, indicating that both chemokines  have 
high affinity for the novel receptor. The IPt0/MigR trans- 
fectants,  by  contrast,  did  not  respond  to  any  of  16  other 
Table  1.  Amino  Acid Sequence Comparison of lPlO/MigR with Human Chemokine Receptors 
IL-8R1  IL-8R2  CC-CKR1  CC-CKR2A  CC-CKR3  CC-CKR4  CC-CKR5  ThromR 
IP10/MigR  40.9*  40.3  34.9  34.2  34.4  35.8  36.9  27.2 
IL8R1  77.1  33.7  32.9  34.3  39.7  34.3  29.1 
IL8R2  34.9  33.6  34.1  40.8  34.4  29.7 
CC-CKR 1  54.1  63.1  49.3  56.3  26.8 
CC-CKR2A  50.7  46.1  68.8  24.6 
CC-CKR3  46.5  52.3  27.3 
CC-CKR4  50.0  29.2 
CC-CKR5  23.6 
*Numbers refer to percentage amino acid identity. Pairwise protein sequence alignments were carried out using the program PALIGN with an open 
gap cost and unit gap cost of 3 and 2, respectively. 
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Figure  2.  Responses  induced 
by IP10 and Mig in stably trans- 
fected  cells expressing  lPl0/ 
MigR.  Concentration-depen- 
dent  [Ca2§  changes  in  IPIO/ 
MigR  transfected  300-19  cells. 
IP10 and Mig were  added at  1, 
10, and lO0-nM to  Fura-2/AM 
loaded  cells  (arrowhead),  and 
[Ca2+]i-dependent  fluorescence 
changes  were  recorded,  Non- 
transfected  cells (lower tracings) 
were  stimulated  with  IP10-or 
Mig at  100  nM under identical 
conditions.  To  test for receptor 
desensitization and cross-desensi- 
tization  IPI0/MigP,  expressing 
300-19  cells were  sequentially 
stimulated with 100 nM IPI0 or 
Mig, and with IPl0 followed by 
Mig or vice  versa, and fluores- 
cence  changes  were  recorded. 
Chemotaxis of IPl0/MigR. expressing Jurkat cells stimulated with IP10 (closed circles) and Mig (closed squares) was determined as described in Materials 
and Methods, The lower panel shows responses of non-transfected Jurkat cells (open symbols).  Mean nunrbers (+-- SD) of migrating cells per five high- 
power fields are presented. 
potential agonists  at concentrations up to  100 nM,  includ- 
ing the  CXC-chemokines  IL-8,  Gl~Oot,  NAP-2,  GCP-2, 
ENA78,  PF4,  the  CC-chemokines  MCP-1,  MCP-2, 
MCP-3,  MCP-4,  MIP-I~x, MIP-1]3,  RANTES,  I309,  eo- 
taxin,  and the  chemokine-related lymphotactin, Identical 
results  were  obtained  with  the  murine  and  the  human 
transfected  ceils.  These  observations  demonstrate  that  the 
novel receptor is highly selective for IPI0 and Mig, and we 
propose  to  name  it  IP10/Mig  receptor  (IPl0/MigR.).  As 
shown in Fig. 2, repeated stimulation with IP10 or Mig re- 
suited in desensitization as commonly observed for chemo- 
kine receptors.  Furthermore, cross-desensitization occurred 
when the cells were stimulated with IPl0 followed by Mig 
or vice versa, confirming that the receptor has high affinity 
for both chemokines. At  100 nM concentration, it became 
evident that  Mig was  more  potent in cross-desensitization 
than IP10, suggesting higher affinity or binding stability of 
IP10/MigR  for Mig. 
Transfected cells expressing the  IP10/MigR  readily mi- 
grated toward IP10 and Mig while the non-transfected, pa- 
rental cells did not respond (Fig. 2). Both agonists showed a 
typically biphasic concentration dependence. IP10 induced 
migration  at  concentrations  above  1  nM  whereas  the  re- 
sponse  of Mig became  detectable above  10  nM.  The  effi- 
cacy,  which is measured by the maximum number of mi- 
grating cells, was about twice as high for Mig than for IPl0. 
These  results  demonstrate  that  the  IP10/MigP,.,  like  all 
known  chemokine  receptors  in leukocytes,  signals for  lo- 
comotion. 
Despite  the  expression  of functional  IP10/MigP,.,  we 
were  unable  to  perform  satisfactory  binding  experiments 
with  radioactive  ligands.  Nonspecific  binding was  always 
between 60  and 80% of the total, preventing the determi- 
nation of the binding parameters.  Since IP10  and Mig are 
highly cationic  (pI values of 10.8  and  11.1),  unspecific in- 
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teraction  with  cell  surface  proteoglycans  may  explain  the 
anomalous  behavior.  Indeed,  chemokine  receptor-unre- 
lated,  heparinase-sensitive binding sites for IP10  (and PF4) 
were detected  on  a variety  of blood  and  tissue  cells  (42), 
and we have  observed that heparan  sulfate binds IP10  and 
Figure  3.  Expression  oflPl(l/MigP. RNA in human blood leukocytes. 
Northern blot analysis was pertbrmed  with  10 Ixg of total  t/.NA  from 
freshly isolated human blood monocytes, neutrophils, lymphocytes (PBL), 
nylon wool-purified  T  cells (PTC),  and from  cultured  cells, including 
cloned  human CD4 + and  C1)8"  T  cells (KT30  and ERCD&  respec- 
tively), cloned  NK cells (ERNK57)  and PBL  cultured  for  1(1 d ill the 
presence of I  L-2 (40(I U/ml). P,  NA samples were analyzed with a 1PI()/ 
MigR I)NA probe as described in Materials and Methods.  Lower panel 
shows ethidium bromide-stained It.NA in the agarose gel bet\~re blotting. 19o] 
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Figure  4.  IPI0 and Mig responses of peripheral blood lymphocytes 
(PBL). Freshly isolated PBL from donor blood huffy coats were used as 
such (lower  tracings  and open symbols) or after culturing for 10 d in the pres- 
ence of IL-2 (400 U/ml) (upper tracings  and closed  symbols). [Ca2+]i  changes 
and chemotaxis were determined as in Fig. 2. 
Mig  and  prevents  lymphocyte  chemotaxis  (data  not 
shown). 
Expression  in Aaivated T-LymphocHes.  In  view  of  the 
observed chemokine selectivity it was of interest  to exam- 
ine the occurrence of the IP10/MigR in leukocytes and re- 
lated cell lines.  As shown in Fig. 3, abundant expression of 
mRNA  of  the  expected  size  was  found  in  the  cloned 
CD4 + T  cells,  KT30, that were used for isolation of the re- 
ceptor cDNA.  Similar levels  of expression  were  observed 
in the CD8 + T  cell clone, ERCD8, and the NK cell clone, 
ERNK57. In freshly isolated blood lymphocytes and nylon 
wool-purified  T  cells,  by contrast,  IP10/MigR  transcripts 
were  barely  detectable.  However,  when  these  cells  were 
cultured in the presence of IL-2, a strong upregulation was 
obtained, and the level of receptor mRNA approached that 
ofT  and NK cell clones.  No IP10/MigR transcripts  were 
found in freshly isolated blood monocytes, neutrophil leu- 
kocytes, eosinophil leukocytes. Additional leukocyte-related 
cells  that did not express  IP10/MigR mRNA  include  the 
mast  cell line,  HMC-1,  the  promyelocytic leukemia  line, 
HL60, the histiocytic lymphoma, U937, the chronic myelog- 
eneous leukemia line, K562, the acute T  cell leukemia line, 
Jurkat,  the  acute  lymphoblastic  leukemia  line,  Molt,  the 
B-lymphoblastic  cell  lines  Daudi  and  Raft,  lymphocytes 
from patients with chronic and acute B-lymphoid leukemia 
(B-CLL and B-ALL), mature basophils from a patient with 
basophilic  leukemia,  and  the  erythroleukemia  cell  line, 
HEL.  By  contrast,  the  receptors  for  chemokines  which 
have  been  shown  previously  to  attract  lymphocytes,  i.e. 
MCP-1,  MCP-2,  MCP-3,  MIP-le~,  MIP-1[3  and 
RANTES  (29,  43-46),  are  also  found  in  monocytes and 
granulocytes. Therefore,  the exclusive expression of IP10/ 
MigR  in  activated  T-lymphocytes  is  an  exciting  finding 
and suggests that this novel receptor may mediate selective 
lymphocyte recruitment. 
Responses of Human  T-Lymphocytes.  In  agreement  with 
the cellular distribution  of the  IP10/MigR,  we found that 
activated  human  T-lymphocytes  are  highly  responsive  to 
IP10 and Mig (Fig. 4). The activity of IP10 and Mig as in- 
ducers of [Ca2+]i  changes and in vitro chemotaxis was con- 
sistent with the effects observed in the transfected cells ex- 
pressing the  IP10/MigR as IP10 was more potent but less 
efficacious than Mig.  Activation of the  T-lymphocytes by 
culturing in the presence of IL-2 was required,  and no re- 
sponse  was  observed  with  freshly  isolated  blood  lym- 
phocytes. 
Two  aspects  of the  present  study  are  noteworthy:  The 
ligand selectivity of the novel receptor and its restricted ex- 
pression  in  activated T-lymphocytes. The receptor recog- 
nizes two unusual  chemokines,  IP10 and Mig.  They both 
belong  to  the  CXC-subfamily,  but  their  target  cells  are 
lymphocytes and not neutrophil leukocytes which respond 
to  IL-8 and  its  numerous  CXC-chemokine  analogs.  The 
expression is also unusual.  IP10 and Mig are induced by in- 
terferon-gamma  which  down-regulates  the  expression  of 
IL-8 (47, 48). In recent years, chemokines were recognized 
as  the  long-sought mediators  for the  recruitment  of lym- 
phocytes.  Several  CC-chemokines  were  found  to  elicit 
lymphocyte chemotaxis  (29),  but  they  are  also  active  on 
monocytes and granulocytes (49,  50).  The situation  is dif- 
ferent for IP10 and Mig which do not share receptors with 
other  chemokines,  and  are  selective  for activated  T-lym- 
phocytes. From the present observations it may be inferred 
that the formation of the characteristic infiltrate in delayed- 
type hypersensitivity lesions, sites of viral infection and cer- 
tain  tumors  may be  regulated  via  IP10/MigR  expression. 
T-lymphocytes that bear this receptor as a result of activa- 
tion are recruited  into  the lesion by IP10 and Mig which 
are induced locally by interferon-gamma.  So far this is the 
only mechanism that can be proposed for the selective re- 
cruitment of T  cells. 
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